AIM ImmunoTech Inc.
AIM
$0.29
-$0.02-5.79%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.18M | -3.28M | -2.79M | -3.71M | -5.97M |
| Total Depreciation and Amortization | 43.00K | 54.00K | 55.00K | 58.00K | 64.00K |
| Total Amortization of Deferred Charges | 300.00K | 69.00K | 119.00K | 64.00K | 69.00K |
| Total Other Non-Cash Items | 1.97M | 408.00K | 306.00K | 432.00K | 464.00K |
| Change in Net Operating Assets | -125.00K | -2.33M | 783.00K | 790.00K | 1.42M |
| Cash from Operations | -1.99M | -5.08M | -1.53M | -2.36M | -3.96M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -95.00K | 296.00K | 754.00K | 898.00K | 3.70M |
| Cash from Investing | -95.00K | 296.00K | 754.00K | 898.00K | 3.70M |
| Total Debt Issued | 2.50M | 0.00 | 250.00K | -- | 0.00 |
| Total Debt Repaid | 0.00 | -660.00K | -- | -- | -251.00K |
| Issuance of Common Stock | -- | 6.92M | 105.00K | 660.00K | 32.00K |
| Repurchase of Common Stock | -6.70M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.92M | 398.00K | -- | -- | 1.26M |
| Cash from Financing | 2.72M | 6.65M | 355.00K | 660.00K | 1.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 638.00K | 1.87M | -422.00K | -803.00K | 786.00K |